Literature DB >> 25700367

PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancer.

Alexander Kikuchi1, Satdarshan Pal Monga.   

Abstract

Platelet-derived growth factor receptor α (PDGFRα) is an isoform of the PDGFR family of tyrosine kinase receptors involved in cell proliferation, survival, differentiation, and growth. In this review, we highlight the role of PDGFRα and the current evidence of its expression and activities in liver development, regeneration, and pathology-including fibrosis, cirrhosis, and liver cancer. Studies elucidating PDGFRα signaling in processes ranging from profibrotic signaling, angiogenesis, and oxidative stress to epithelial-to-mesenchymal transition point toward PDGFRα as a potential therapeutic target in various hepatic pathologies, including hepatic fibrosis and liver cancer. Furthermore, PDGFRα localization and modulation during liver development and regeneration may lend insight into its potential roles in various pathologic states. We will also briefly discuss some of the current targeted treatments for PDGFRα, including multi receptor tyrosine kinase inhibitors and PDGFRα-specific inhibitors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25700367      PMCID: PMC4410163          DOI: 10.3727/105221615X14181438356210

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  134 in total

1.  Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis.

Authors:  Dominique Thabut; Chittaranjan Routray; Gwen Lomberk; Uday Shergill; Kevin Glaser; Robert Huebert; Leena Patel; Tetyana Masyuk; Boris Blechacz; Andrew Vercnocke; Erik Ritman; Richard Ehman; Raul Urrutia; Vijay Shah
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

2.  KDR identifies a conserved human and murine hepatic progenitor and instructs early liver development.

Authors:  Orit Goldman; Songyan Han; Marion Sourisseau; Marion Sourrisseau; Noelle Dziedzic; Wissam Hamou; Barbara Corneo; Sunita D'Souza; Thomas Sato; Darrell N Kotton; Karl-Dimiter Bissig; Tamara Kalir; Adam Jacobs; Todd Evans; Matthew J Evans; Valerie Gouon-Evans
Journal:  Cell Stem Cell       Date:  2013-06-06       Impact factor: 24.633

3.  Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma.

Authors:  Sameer H Patel; Peter J Kneuertz; Maria Delgado; David A Kooby; Charles A Staley; Bassel F El-Rayes; John S Kauh; Juan M Sarmiento; Steven Hanish; Cynthia Cohen; Alton B Farris; Shishir K Maithel
Journal:  Ann Surg Oncol       Date:  2011-05-18       Impact factor: 5.344

4.  Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis.

Authors:  Jean S Campbell; Melissa M Johnson; Renay L Bauer; Kelly L Hudkins; Debra G Gilbertson; Kimberly J Riehle; Matthew M Yeh; Charles E Alpers; Nelson Fausto
Journal:  Differentiation       Date:  2007-11       Impact factor: 3.880

5.  Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge.

Authors:  F van Zijl; M Mair; A Csiszar; D Schneller; G Zulehner; H Huber; R Eferl; H Beug; H Dolznig; W Mikulits
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

Review 6.  Molecular therapy for hepatic injury and fibrosis: where are we?

Authors:  Colette C Prosser; Roy D Yen; Jian Wu
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

7.  Role of nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways in IL-1 beta-mediated induction of alpha-PDGF receptor expression in rat pulmonary myofibroblasts.

Authors:  P M Lindroos; A B Rice; Y Z Wang; J C Bonner
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

Review 8.  Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors:  Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal:  Gut       Date:  2014-02-14       Impact factor: 23.059

Review 9.  Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.

Authors:  Monica Marra; Ignazio M Sordelli; Angela Lombardi; Monica Lamberti; Luciano Tarantino; Aldo Giudice; Paola Stiuso; Alberto Abbruzzese; Rossella Sperlongano; Marina Accardo; Massimo Agresti; Michele Caraglia; Pasquale Sperlongano
Journal:  J Transl Med       Date:  2011-10-10       Impact factor: 5.531

10.  Activation of platelet-derived growth factor receptor alpha contributes to liver fibrosis.

Authors:  Brian J Hayes; Kimberly J Riehle; Masami Shimizu-Albergine; Renay L Bauer; Kelly L Hudkins; Fredrik Johansson; Matthew M Yeh; William M Mahoney; Raymond S Yeung; Jean S Campbell
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

View more
  19 in total

1.  Platelet-Derived Growth Factor Receptor α Contributes to Human Hepatic Stellate Cell Proliferation and Migration.

Authors:  Alexander Kikuchi; Tirthadipa Pradhan-Sundd; Sucha Singh; Shanmugam Nagarajan; Nick Loizos; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2017-07-20       Impact factor: 4.307

2.  Elimination of Wnt Secretion From Stellate Cells Is Dispensable for Zonation and Development of Liver Fibrosis Following Hepatobiliary Injury.

Authors:  Rong Zhang; Alexander T Kikuchi; Toshimasa Nakao; Jacquelyn O Russell; Morgan E Preziosi; Minakshi Poddar; Sucha Singh; Aaron W Bell; Steven G England; Satdarshan P Monga
Journal:  Gene Expr       Date:  2018-09-20

3.  Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.

Authors:  Jinhang Gao; Bo Wei; Thiago M de Assuncao; Zhikui Liu; Xiao Hu; Samar Ibrahim; Shawna A Cooper; Sheng Cao; Vijay H Shah; Enis Kostallari
Journal:  J Hepatol       Date:  2020-05-08       Impact factor: 25.083

4.  Hepatic stellate cell-derived platelet-derived growth factor receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2.

Authors:  Enis Kostallari; Petra Hirsova; Alena Prasnicka; Vikas K Verma; Usman Yaqoob; Nicha Wongjarupong; Lewis R Roberts; Vijay H Shah
Journal:  Hepatology       Date:  2018-05-10       Impact factor: 17.425

5.  Synectin promotes fibrogenesis by regulating PDGFR isoforms through distinct mechanisms.

Authors:  Mary C Drinane; Usman Yaqoob; Haibin Yu; Fanghong Luo; Thomas Greuter; Juan P Arab; Enis Kostallari; Vikas K Verma; Jessica Maiers; Thiago Milech De Assuncao; Michael Simons; Debabrata Mukhopadhyay; Tatiana Kisseleva; David A Brenner; Raul Urrutia; Gwen Lomberk; Yandong Gao; Giovanni Ligresti; Daniel J Tschumperlin; Alexander Revzin; Sheng Cao; Vijay H Shah
Journal:  JCI Insight       Date:  2017-12-21

6.  Hepatic Stellate Cell-Specific Platelet-Derived Growth Factor Receptor-α Loss Reduces Fibrosis and Promotes Repair after Hepatocellular Injury.

Authors:  Alexander Kikuchi; Sucha Singh; Minakshi Poddar; Toshimasa Nakao; Heidi Marie Schmidt; Jenesis D Gayden; Toshifumi Sato; Gavin E Arteel; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2020-06-29       Impact factor: 4.307

7.  microRNA-140 Regulates PDGFRα and Is Involved in Adipocyte Differentiation.

Authors:  Yi Yan; Jiahui Yuan; Xiaomao Luo; Xiuju Yu; Jiayin Lu; Wei Hou; Xiaoyan He; Liping Zhang; Jing Cao; Haidong Wang
Journal:  Front Mol Biosci       Date:  2022-06-27

8.  Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver Fibrosis in Human Hepatic Stellate Cells.

Authors:  Shan Yu; Matthew Ericson; Andrea Fanjul; Derek M Erion; Maria Paraskevopoulou; Erin N Smith; Banumathi Cole; Ryan Feaver; Corine Holub; Narender Gavva; Shane R Horman; Jie Huang
Journal:  ACS Chem Biol       Date:  2022-03-11       Impact factor: 4.634

9.  MiR-630 suppresses breast cancer progression by targeting metadherin.

Authors:  Ci-Xiang Zhou; Chen-Long Wang; An-Lu Yu; Qiu-Yu Wang; Meng-Na Zhan; Jun Tang; Xiu-Feng Gong; Qian-Qian Yin; Ming He; Jian-Rong He; Guo-Qiang Chen; Qian Zhao
Journal:  Oncotarget       Date:  2016-01-12

10.  CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway.

Authors:  Qi Wang; Yong Tang; Hongjing Yu; Qiaoyun Yin; Mengdi Li; Lijun Shi; Wei Zhang; Danrong Li; Li Li
Journal:  Mol Carcinog       Date:  2015-10-12       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.